The diagnosis of MPS IVA is established after detection of the reduced GALNS activity in leukocytes or fibroblasts, followed by the identification of biallelic variants in the GALNS gene (Sawamoto, et al. 2020). Here, GALNS is linked to mucopolysaccharidosis type 4A.